- Home
- BYAH vs OSRH Comparison
BYAH vs OSRH Comparison
Compare BYAH & OSRH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BYAH
- OSRH
- Stock Information
- Founded
- BYAH 2016
- OSRH N/A
- Country
- BYAH China
- OSRH United States
- Employees
- BYAH N/A
- OSRH N/A
- Industry
- BYAH Package Goods/Cosmetics
- OSRH
- Sector
- BYAH Consumer Discretionary
- OSRH
- Exchange
- BYAH Nasdaq
- OSRH Nasdaq
- Market Cap
- BYAH 10.8M
- OSRH 12.5M
- IPO Year
- BYAH 2024
- OSRH N/A
- Fundamental
- Price
- BYAH $0.25
- OSRH $0.65
- Analyst Decision
- BYAH
- OSRH
- Analyst Count
- BYAH 0
- OSRH 0
- Target Price
- BYAH N/A
- OSRH N/A
- AVG Volume (30 Days)
- BYAH 242.0K
- OSRH 9.5M
- Earning Date
- BYAH 08-26-2025
- OSRH 11-12-2025
- Dividend Yield
- BYAH N/A
- OSRH N/A
- EPS Growth
- BYAH N/A
- OSRH N/A
- EPS
- BYAH N/A
- OSRH N/A
- Revenue
- BYAH $2,768,120.00
- OSRH N/A
- Revenue This Year
- BYAH N/A
- OSRH N/A
- Revenue Next Year
- BYAH N/A
- OSRH N/A
- P/E Ratio
- BYAH N/A
- OSRH N/A
- Revenue Growth
- BYAH 42.65
- OSRH N/A
- 52 Week Low
- BYAH $0.25
- OSRH $0.45
- 52 Week High
- BYAH $41.49
- OSRH $12.54
- Technical
- Relative Strength Index (RSI)
- BYAH N/A
- OSRH 54.35
- Support Level
- BYAH N/A
- OSRH $0.46
- Resistance Level
- BYAH N/A
- OSRH $0.75
- Average True Range (ATR)
- BYAH 0.00
- OSRH 0.07
- MACD
- BYAH 0.00
- OSRH 0.00
- Stochastic Oscillator
- BYAH 0.00
- OSRH 60.20
About BYAH Park Ha Biological Technology Co. Ltd. Ordinary Shares
Park Ha Biological Technology Co Ltd is engaged in developing its private skincare label, direct skincare products sales and franchise alliances promotions. Its Park Ha brand focuses on providing solutions for problematic skin. The company's Operating Subsidiaries provide skincare and cosmetic products under its brand, Park Ha in China. Its Operating Subsidiaries develop its proprietary beauty products and offer complimentary after-sales beauty services in its physical stores.
About OSRH OSR Holdings Inc. Common Stock
OSR Holdings Inc is a healthcare company dedicated to healthcare outcomes and improving the quality of life for people and their families. It builds and develops a robust portfolio of potentially transformative therapies and healthcare solutions. The business of the company includes developing oral immunotherapies for the treatment of cancer, developing design-augmented biologics for age-related and other degenerative diseases, and neurovascular intervention medical device and systems distribution in Korea.